Medici Brands Unveils Rowdy as Third Label, Targeting the Chip Aisle

Medici Brands, the multi-brand food platform behind David Protein and HallPass, has unveiled Rowdy as its third consumer label, moving into the salty snacks category with a chip-focused line expected to reach market before the end of the year.

The disclosure follows the close of a $250 million Series B for Medici, with the company indicating that the capital will be deployed to support new brand launches and build out the shared infrastructure underlying its growing portfolio. Rowdy marks the platform's entry into a third distinct product category, completing an initial arc that spans high-protein foods, candy and now chips.

By assembling brands across protein, confectionery and salty snacks under a single operating entity, Medici is positioning itself less as a brand company and more as a category aggregator, a model that allows shared logistics, retail relationships and back-office functions to serve multiple consumer-facing identities at once. The $250 million raise gives the company meaningful resources to absorb the investment typically required to launch a brand from a standing start in a crowded aisle.

Why it matters

The chip and salty snacks segment is among the most competitive in food retail. Legacy conglomerates hold dominant share, and a generation of better-for-you challengers has already crowded the innovation tier. Medici's decision to enter with an entirely new brand, rather than acquiring an existing player, is a notable strategic bet that its platform infrastructure can build brand equity efficiently enough to compete.

The multi-brand platform model has long been standard practice in beauty and personal care, where operators bundle distinct labels under shared operational roofs to reduce per-unit cost. Its migration into CPG food has been gradual but is now gathering pace, as investors look for structures that can support category diversification without proportional overhead growth. A $250 million Series B positions Medici as one of the better-capitalized examples of this approach currently operating in food.

Rowdy's anticipated 2026 launch will also serve as an early test of how effectively Medici can use its existing retail relationships, likely built through David Protein's distribution, to seed a brand in a meaningfully different product category.

What to watch

The central open question is how Rowdy will be positioned within the chip category. Medici's existing portfolio is anchored in protein and better-for-you nutrition, and if Rowdy adopts similar framing it would enter a defined but increasingly competitive segment of the snack aisle. A more mainstream, flavor-first approach would signal that Medici is willing to operate brands with distinct consumer targets, which carries its own distribution and marketing complexity. That positioning choice will determine which retail partners Medici pursues first and how quickly Rowdy can build the velocity needed to earn permanent shelf placement alongside established names.

Featured on @cpglatest: see the post